Similar articles

Abstract: Objective: To study the effects of different concentrations of antisense oligodeoxynucleotides (ASODN) on human pancreatic cancer cell line PaTu8988s. Method: Human pancreatic cancer cell line PaTu8988s in exponential growth stage was used to study the effect of different drug concentrations on the cell line in the presence of different concentrations (0 μg/ml, 5 μg/ml, 25 μg/ml, 50 μg/ml, 100 μg/ml, 200 μg/ml) of ASODN and sense oligodeoxynucleotides (SODN). Cell counts and 3-[4,5-dimethylthiazolzyl]-2,5-diphenyl tetrazolium bromide (MTT) assays were carried out. Results: The inhibitory rate on the cell line PaTu8988s was 98.73%, 95.76%, 69.49%, 33.05% and 0 for ASODM concentrations of 200 μg/ml, 100 μg/ml, 50 μg/ml, 25 μg/ml and 5 μg/ml at 48 hours. Conclusions: k-ras complementary ASODN can inhibit the growth of human pancreatic cancer cell line PaTu8988s by 30.05% to 98.73%. This is likely to contribute to the specificity of the k-ras mRNA complementary capped ASODN sequential codon. Non-specific effect and side effect of ASOND were observed for instance, the greater the concentration is, the earlier the peak of inhibitory rate is reached. In concentration of 25 μg/ml to 100 μg/ml ASODN showed a dose-effect correlation.

[1] Augustine, K., 1997. Antisense approaches for investigting mechanisms of abnoral development. Mutat Res 396(1-2):175.

[2] Bartsch, D., Bastian, D., Barth, P., et al., 1998. K-ras oncogene mutations indicate malignancy in cystic tumors of the pancreas. Ann Surg, 228(1): 79-86.

[3] Cai Jianting, Qian Keda, Lu Junsheng, 2000. Effect of antisense oligodeoxynucleotides on human pancreatic cancer cell line PaTu 8988s at different times after treatment. Chin J Dig. 20(6):378-379 (in Chinese).

[4] Duroux, I., Godard, G., Boidit, FM., 1995. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells. Nucleic Acids Res., 23(17): 3411-3418.

[5] Iversen, P., Mata, J., Traceweel, W., et al., 1994. Pharmacokinetics of an antisense phosphorothioate oligodeoxynucleotide against adult male rat following single injections and continuous infusion. Antisense Res 4:99.

[6] Liu Tonghua, Li Dechun, Wang Zhiyong, 1993.The inhibitory effect of antisense oligodeoxynucleotides on the growth of human pancreatic adenocarcioma cell lines. Chin J Pathol. 22(1): 25-29. (In Chinese)

[7] Van laethem JL, Bourgeois, V., Parma. J., et al., 1998. Relative contribution of Ki-ras gene analysis and brush cytology during ERCP for the diagnosis of biliary and pancreatic diseases. Gastrointest Endosc, 47(6): 479-485.